The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision

Imad J. Matouk _, David Halle, Eli Raveh, Michal Gilon, Vladimir Sorin and Avraham Hochberg

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:3748-3765. https://doi.org/10.18632/oncotarget.6387

Metrics: PDF 3601 views  |   HTML 3694 views  |   ?  


Imad J. Matouk1,2,*, David Halle1, Eli Raveh1, Michal Gilon1, Vladimir Sorin1 and Avraham Hochberg1

1 Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel

2 Department of Biological Sciences, Faculty of Science and Technology, Al-Quds University, Jerusalem, West Bank

Correspondence to:

Imad J. Matouk, email:

Keywords: H19, miR-675, metastasis, lncRNA, EMT, MET

Received: June 16, 2015 Accepted: November 15, 2015 Published: November 25, 2015


Long non-coding RNA (lncRNA) genes are emerging as key players in the metastatic cascade. Current evidence indicate that H19 lncRNA and the microRNA(miRNA) miR-675, which is processed from it, play crucial roles in metastasis, through the regulation of critical events specifically the epithelial to mesenchymal (EMT) and the mesenchymal to epithelial transitions (MET). This review summarizes recent mechanistic pathways and tries to put together seemingly conflicting data from different reports under one proposed general scheme underlying the various roles of H19/miR-675 in the metastatic cascade. We propose several approaches to harnessing this knowledge for translational medicine.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6387